Drug Delivery Based on Nanotechnology for Target Bone Disease

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Orthopedics
• Drug Delivery Systems

Background:

• Bone diseases pose a significant health challenge, exacerbated by global population aging.
• Drug delivery to bone lesions is difficult due to tissue-specific physiology and microenvironment.
• Traditional orthopedic treatments often involve high drug frequencies, large doses, and significant side effects.

Purpose of the Study:

• To review the application of nanotechnology in targeted therapies for bone diseases.
• To explore innovative strategies for precise drug delivery to bone tissue and target cells.
• To highlight methods for reducing systemic toxicity associated with orthopedic drug treatments.

Main Methods:

• Review of current research on nanotechnology-based drug delivery systems for bone diseases.
• Analysis of targeted drug delivery strategies utilizing nano-carriers with targeting groups.
• Examination of in situ drug delivery approaches using bone tissue engineering scaffolds and biomaterials.

Main Results:

• Nano drug delivery systems enable precise orthopedic drug delivery, significantly reducing systemic toxicity.
• Targeting groups enhance the specificity of nano-carriers for bone tissue and target cells.
• Tissue engineering scaffolds and biomaterials show promise for localized, in situ drug release.

Conclusions:

• Nanotechnology provides a promising avenue for targeted therapies in bone diseases.
• Targeted nano-drug delivery systems can improve treatment efficacy and minimize adverse effects.
• Further research into nanomedicine and biomaterials is crucial for advancing orthopedic treatments.